Based on the correlation of HAI-1 with CRC prognosis and cetuximab response in cancer databases and cell lines, we hypothesized that HAI-1 addition or overexpression would induce cetuximab sensitivity in HGF/MET-dependent cetuximab-resistant lines. The gene discussed is MET; the disease is colorectal carcinoma.